Pulmatrix's Total Assets for the quarter that ended in Dec. 2023 was $33.96 Mil.
During the past 12 months, Pulmatrix's average Total Assets Growth Rate was 177.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 31.90% per year.
During the past 5 years, the average Total Assets Growth Rate was -5.20% per year.
During the past 10 years, the average Total Assets Growth Rate was 77.40% per year.
During the past 12 years, Pulmatrix's highest 3-Year average Total Assets Growth Rate was 1254.60%. The lowest was -25.80%. And the median was 16.20%.
Total Assets is connected with ROA %. Pulmatrix's annualizedROA % for the quarter that ended in Dec. 2023 was -23.56%. Total Assets is also linked to Revenue through Asset Turnover. Pulmatrix's Asset Turnover for the quarter that ended in Dec. 2023 was 0.06.
Pulmatrix Total Assets Historical Data
The historical data trend for Pulmatrix's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Pulmatrix's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Pulmatrix's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Pulmatrix Total Assets Related Terms
Thank you for viewing the detailed overview of Pulmatrix's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PULM has been successfully added to your 